Initial unemployment filings in Virginia rose by over 27% last week, contrasting with a slight national decline and highlighting regional economic disparities.
CareDx CEO John Hanna sold over 19,000 shares under a pre-arranged trading plan, a move that comes as the transplant diagnostics firm posts strong revenue growth but continues to navigate a challenging stock market environment.
Investor Kevin O'Leary argues that rigid return-to-office policies are a competitive disadvantage, pushing high performers toward flexible employers and leaving companies with a diminished talent pool.
Air Products and Chemicals reported a 10% rise in adjusted EPS for its fiscal first quarter, driven by strategic pricing and productivity gains. While management affirmed full-year guidance, they highlighted persistent challenges in the helium market and a cautious approach to major clean energy investments.
The automotive safety giant posted historic sales and cash flow in 2025, powered by explosive growth with Chinese automakers and in India. While navigating a softer production forecast and tariff headwinds, management projects margin expansion for 2026.
Oxford Lane Capital (OXLC) reported a challenging third fiscal quarter, marked by a significant drop in net asset value and investment income, prompting management to reduce its monthly distribution. The firm cited volatile conditions in the CLO and leveraged loan markets as key headwinds, while outlining a strategy to preserve capital for opportunistic investments.
Despite a challenging mortgage landscape and specific credit headwinds, Hilltop Holdings Inc. (HTH) reported a 46% surge in annual net income for 2025, buoyed by a steepening yield curve and disciplined cost management across its banking, lending, and securities divisions.
CLEAR Secure, the biometric identity company known for its airport expedited lanes, is deepening its ties to core government systems. CEO Caryn Seidman Becker's appointment to the Federal Reserve Bank of New York's board and a new contract with the Centers for Medicare & Medicaid Services signal a strategic push into financial and public health infrastructure.
The trading platform's launch of commission-free event contracts for the Big Game has sparked interest, but its shares continue to struggle, raising questions about its valuation and growth narrative.
Minerals 260 (ASX:MI6) has significantly upgraded the resource estimate at its flagship Bullabulling gold project to 4.5 million ounces, sparking renewed investor interest. Despite recent share price volatility, the long-term outlook appears buoyed by upcoming study milestones and a substantial intrinsic value gap, raising questions about whether the market is undervaluing its potential.
Energy giant Drax has secured a decade-long tolling agreement with Fidra Energy for a new 250MW battery storage system in Nottinghamshire, marking a capital-light expansion of its flexible generation portfolio as the UK races to decarbonise.
Chemed Corporation (NYSE: CHE) has seen its share price soften recently, reigniting investor debate over whether the healthcare services provider is now undervalued. With the stock trading around $430, a significant gap exists against some fair value estimates, even as operational challenges in its VITAS and Roto-Rooter segments loom.
United Natural Foods, Inc. launches a landmark grant program across all 50 U.S. states and Canada to celebrate its 50th year, even as its stock performance presents a mixed picture for value-focused investors.
A revised price target for Invesco Mortgage Capital (IVR) is prompting investors to reassess the mortgage REIT's trajectory amid evolving interest rate expectations and housing market dynamics.
Ahead of its February 26 earnings report, Medical Properties Trust (NYSE: MPW) is witnessing a notable spike in options activity, with call volume soaring to roughly five times its usual level. This surge in speculative interest comes as the healthcare REIT's shares hover around $5.05, showing recent momentum but still grappling with a challenging multi-year performance. Analysts are divided on whether the stock's current price reflects lingering past troubles or is beginning to price in a potential recovery narrative.
Discount retailer Five Below is under investigation by law firm Johnson Fistel following declining sales, lowered guidance, and the sudden departure of its CEO. The legal scrutiny comes as the stock shows sharp volatility—up nearly 96% over the past year but down year-to-date—raising questions about its valuation and growth narrative.
As Comcast shares languish near multi-year lows, a stark divide emerges between its market price and fundamental valuations. We examine whether the telecom and media giant's cash flow potential justifies a contrarian bet.
Bilt's transition to a tiered rewards system forces its user base, largely comprised of renters, to recalculate the card's value. The changes, which require higher spending to unlock points on rent, have sparked confusion and a critical decision ahead of a fast-approaching deadline.
Analysts at Truist reaffirm their Buy rating on DLocal (DLO), raising their price target to $17 ahead of the fintech firm's Q4 2025 earnings. While expecting solid results, they flag challenging year-over-year volume comparisons that may cap upside surprises.
Rosenblatt Securities initiates coverage on Credo Technology with a Neutral rating and a $170 price target, highlighting its strong position in high-speed connectivity for AI infrastructure while flagging competitive pressures. The note follows a more bullish target hike from Barclays earlier in the month.
